ISPOR 2020 Panel: Will APMs incentivize high-value medications?

Published on:

Tomorrow, Monday, May 18, I will be moderating a panel with Dr. Bapu Jena of Harvard University, Elizabeth Oyekan of PRECISIONvalue and Michael Barr of National Committee for Quality Assurance (NCQA). The topic is:

WILL ALTERNATIVE PAYMENT MODELS INCENTIVIZE HEALTH SYSTEMS TO PRESCRIBE HIGH VALUE MEDICATIONS AND SUPPORT BETTER CLINICAL OUTCOMES?

ISSUE:Recent decades have seen a dramatic rise in the share of provider payments that are linked to value. Increased use of alternative payment models could improve efficiency if these models incentivize providers to better balance clinical outcomes with treatment cost. On the other hand, quality measurement is imperfect and

Read more    Source: healthcare-economist.com

Leave a Reply